Type
Closure
Country
Germany
Region
Hessen; Gießen; Limburg-Weilburg
Location of affected unit(s)
Limburg an der Lahn
Sector
Manufacturing
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations

594 jobs
Number of planned job losses
Job loss
Announcement Date
30 September 2017
Employment effect (start)
30 September 2017
Foreseen end date
31 December 2018

Description

On 30 September 2017, the German pharmaceutical company Mundipharma announced it will close its site in Limburg, which will result in the loss of 594 jobs. The marketing and sales department will downsize to 174 workers and the unit will relocate to Frankfurt am Main. Mundipharma's research and development activities will relocate to Cambridge. Production will relocate within Europe, for which the destination has yet to be announced.

In March 2017, Mundipharma announced it would close the site in Limburg. Since then, of former 770 employees, 110 have already voluntarily left the company. Management and works council have reached an agreement regarding a social plan. Details have not been announced.


Sources

  • 30 September 2017: Nassauische Neue Presse Online
  • 6 October 2017: Frankfurter Neue Presse (online)

Citation

Eurofound (2017), Mundipharma, Closure in Germany, factsheet number 92219, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/92219.